Citius Pharmaceuticals, Inc. CTXR
Set alert
0.56 USD +0.04 +7.44%
At close · Nov 2
0.56 0.00 -0.59%
After hours · Nov 2, 4:28 PM ET
0.52 Day range 0.5695
0.37 52-week range 1.60
- YTD
- -27.67%
- 1 year
- -64.43%
- Open
- 0.5284
- Prev close
- 0.5231
- Mkt cap
- 15.43M
- Vol
- 372.74K
- Avg vol
- 472.24K
- EPS
- -1.75
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.52
- High
- 0.5695
- Forward P/E
- 15.32
- Beta
- 1.66
- Short ratio
- 1.23
- Inst. own
- 13.17%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jan 3, 2025
- 50-d avg
- 6.51
- 200-d avg
- 14.50
- 1y target
- 54.00
MAX chart
Events in this range
- Aug 5, 2024Rating: EF Hutton · Buy → Buy
- Jan 3, 2025Earnings: —; estimate -2; surprise —%
Signals (31)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Dec 1, 2025 | 11 months ago |
| SMA: Bullish | Oct 1, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 1, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 1, 2024 | 2 years ago |
| SMA: Bearish | Aug 1, 2024 | 2 years ago |
| SMA: Bullish | Jul 1, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 1, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 1, 2024 | 2 years ago |
| SMA: Bearish | Apr 1, 2024 | 2 years ago |
| SMA: Bullish | Mar 1, 2024 | 2 years ago |
| MACD: Buy Signal | Mar 1, 2024 | 2 years ago |
| MACD: Sell Signal | Sep 1, 2023 | 3 years ago |
| SMA: Bearish | Jul 1, 2023 | 3 years ago |
| SMA: Bullish | Jun 1, 2023 | 3 years ago |
| SMA: Bearish | May 1, 2023 | 3 years ago |
| SMA: Bullish | Jan 1, 2023 | 3 years ago |
| MACD: Buy Signal | Jan 1, 2023 | 3 years ago |
| SMA: Bearish | Apr 1, 2022 | 4 years ago |
| MACD: Sell Signal | Apr 1, 2022 | 4 years ago |
| SMA: Bearish | Oct 1, 2021 | 5 years ago |
| SMA: Bullish | Jan 1, 2021 | 5 years ago |
| SMA: Bullish | Apr 1, 2020 | 6 years ago |
| SMA: Bearish | Feb 1, 2020 | 6 years ago |
| SMA: Bullish | Dec 1, 2019 | 6 years ago |
| SMA: Bearish | Aug 1, 2019 | 7 years ago |
| SMA: Bullish | Jul 1, 2019 | 7 years ago |
| MACD: Buy Signal | Feb 1, 2018 | 8 years ago |
| SMA: Bearish | May 1, 2016 | 10 years ago |
| RSI: Overbought | Feb 1, 2016 | 10 years ago |
| SMA: Bullish | Dec 1, 2015 | 10 years ago |
| SMA: Bearish | Oct 1, 2015 | 11 years ago |
Financial health
Altman Z-Score
-4.04 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 5
Valuation
P/E -0.4×
FY 2016 5y median -3.1× FY 2025
P/S 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.2×
FY 2016 5y median 1.7× FY 2025
P/FCF -0.5×
FY 2016 5y median -3.6× FY 2025
EV/EBITDA -0.3×
FY 2016 5y median -3.7× FY 2025
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -193.5%
FY 2016 5y median -28.1% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -55.4%
FY 2016 5y median -35.8% FY 2025
ROIC -44.2%
FY 2016 5y median -37.5% FY 2025
ROA -28.6%
FY 2016 5y median -29.5% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income 8.3%
FY 2016 FY 2025
EPS (diluted) 43.4%
FY 2016 FY 2025
Free Cash Flow 5.8%
FY 2016 FY 2025
Financial Health
Current Ratio 0.6×
FY 2016 5y median 5.9× FY 2025
Quick Ratio 0.1×
FY 2016 5y median 5.9× FY 2025
Debt / Equity 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.1×
FY 2016 5y median 0.7× FY 2025
Interest Coverage -144×
FY 2016 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-09-30